Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatic arterial infusion chemotherapy for unresectable intrahepatic cholangiocarcinoma
ChiCTR1800020427Phase 2Recruiting
- Sponsor
- Sun Yat-sen University Cancer Center
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of FOLFOX in intrahepatic cholangiocarcinoma (ICC), sponsored by Sun Yat-sen University Cancer Center. Primary endpoint: Progression-free survival time. Started Jan 2019; status: recruiting.
02
Drugs
FOLFOX
03
Conditions
intrahepatic cholangiocarcinoma (ICC)
Beyond the preview
Go deeper on ChiCTR1800020427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800020427.